Representing the SMART study investigator group. A phase III randomized mutlinational study of Monoclonal Antibody Immuno Therapy (SMART) with R1549 (90Y-huHMFG1) in patients with epithelial ovarian cancer (EOC)

M.V. Seiden; BB Benigno; LFAG Massuger; RHM Verheijen; A. Lopes; JT Soper; J. Markowska; R Vyzula; H. Lambert; AA Epenetos

Representing the SMART study investigator group. A phase III randomized mutlinational study of Monoclonal Antibody Immuno Therapy (SMART) with R1549 (90Y-huHMFG1) in patients with epithelial ovarian cancer (EOC)

M.V. Seiden, BB Benigno, LFAG Massuger, RHM Verheijen, A. Lopes, JT Soper, J. Markowska, R Vyzula, H. Lambert, AA Epenetos

Research output: Contribution to conference › Abstract › Other research output

Original language	English
Publication status	Published - 2004
Event	ASCO - New Orleans, United States Duration: 4 Jun 2004 → 8 Jun 2004

Conference

Conference	ASCO
Country/Territory	United States
City	New Orleans
Period	4/06/04 → 8/06/04

Cite this

Seiden, M. V., Benigno, BB., Massuger, LFAG., Verheijen, RHM., Lopes, A., Soper, JT., Markowska, J., Vyzula, R., Lambert, H., & Epenetos, AA. (2004). Representing the SMART study investigator group. A phase III randomized mutlinational study of Monoclonal Antibody Immuno Therapy (SMART) with R1549 (90Y-huHMFG1) in patients with epithelial ovarian cancer (EOC). Abstract from ASCO, New Orleans, United States.

@conference{a8b5b423aad3405d91e9610dc4bec055,

title = "Representing the SMART study investigator group. A phase III randomized mutlinational study of Monoclonal Antibody Immuno Therapy (SMART) with R1549 (90Y-huHMFG1) in patients with epithelial ovarian cancer (EOC)",

author = "M.V. Seiden and BB Benigno and LFAG Massuger and RHM Verheijen and A. Lopes and JT Soper and J. Markowska and R Vyzula and H. Lambert and AA Epenetos",

year = "2004",

language = "English",

note = "ASCO ; Conference date: 04-06-2004 Through 08-06-2004",

}

Seiden, MV, Benigno, BB, Massuger, LFAG, Verheijen, RHM, Lopes, A, Soper, JT, Markowska, J, Vyzula, R, Lambert, H & Epenetos, AA 2004, 'Representing the SMART study investigator group. A phase III randomized mutlinational study of Monoclonal Antibody Immuno Therapy (SMART) with R1549 (90Y-huHMFG1) in patients with epithelial ovarian cancer (EOC)', ASCO, New Orleans, United States, 4/06/04 - 8/06/04.

Representing the SMART study investigator group. A phase III randomized mutlinational study of Monoclonal Antibody Immuno Therapy (SMART) with R1549 (90Y-huHMFG1) in patients with epithelial ovarian cancer (EOC). / Seiden, M.V.; Benigno, BB; Massuger, LFAG et al.
2004. Abstract from ASCO, New Orleans, United States.

Research output: Contribution to conference › Abstract › Other research output

TY - CONF

T1 - Representing the SMART study investigator group. A phase III randomized mutlinational study of Monoclonal Antibody Immuno Therapy (SMART) with R1549 (90Y-huHMFG1) in patients with epithelial ovarian cancer (EOC)

AU - Seiden, M.V.

AU - Benigno, BB

AU - Massuger, LFAG

AU - Verheijen, RHM

AU - Lopes, A.

AU - Soper, JT

AU - Markowska, J.

AU - Vyzula, R

AU - Lambert, H.

AU - Epenetos, AA

PY - 2004

Y1 - 2004

M3 - Abstract

T2 - ASCO

Y2 - 4 June 2004 through 8 June 2004

ER -